Detection of Occult Micrometastases in Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance) [Thoracic Oncology]
Conclusion
NSCLC tumor markers can be detected in histologically negative LNs by AE1/AE3 IHC and carcinoembryonic antigen RT-PCR. In this prospective, multi-institutional trial, the presence of OM by IHC staining in N2 LNs of patients with NSCLC correlated with decreased OS. The clinical significance of this warrants further investigation.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Martin, DCunha, Wang, Herzan, Gu, Abraham, Demmy, Detterbeck, Groth, Harpole, Krasna, Kernstine, Kohman, Patterson, Sugarbaker, Vollmer, Maddaus, Kratzke Tags: Clinical Trials, Diagnosis & Staging, Surgery, Pathology Thoracic Oncology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Cardiovascular & Thoracic Surgery | Clinical Trials | Leukemia | Lung Cancer | Non-Small Cell Lung Cancer | Pathology | Squamous Cell Carcinoma | Statistics | Study